Annual report pursuant to Section 13 and 15(d)

Document and Entity Information

Document and Entity Information - USD ($)
12 Months Ended
Dec. 31, 2021
Jul. 03, 2022
Jun. 30, 2021
Cover [Abstract]      
Document Type 10-K/A    
Amendment Description Amendment No. 1    
Document Annual Report true    
Document Transition Report false    
Document Period End Date Dec. 31, 2021    
Entity File Number 001-36672    
Entity Registrant Name KIORA PHARMACEUTICALS, INC    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 98-0443284    
Entity Address, Address Line One 1371 East 2100 South    
Entity Address, Address Line Two Suite 200    
Entity Address, City or Town Salt Lake City    
Entity Address, State or Province UT    
Entity Address, Postal Zip Code 84105    
City Area Code 781    
Local Phone Number 788-8869    
Title of 12(b) Security Common Stock, $0.01 par value    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company false    
Entity Shell Company false    
Trading Symbol KPRX    
Entity Public Float     $ 45,594,207
Entity Common Stock, Shares Outstanding   13,067,426  
Entity Central Index Key 0001372514    
Current Fiscal Year End Date --12-31    
Document Fiscal Year Focus 2021    
Document Fiscal Period Focus FY    
Amendment Flag true    
Auditor Name EISNERAMPER LLP    
Auditor Firm ID 274    
Auditor Location New York